latest update:
[TrialBase DB]

trial summary · NCT07810517

Lactobacillus Acidophilus and Inulin for Cognitive Impairment in Obesity

Effect of Lactobacillus Acidophilus Combined With Inulin on Cognitive Impairment in Patients With Obesity

Trial record from the TrialBase DB dataset, status RECRUITING, condition Obesity (Disorder), sponsored by Anahuac University. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07810517phase —enrollment 40start 2026-11-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This randomized crossover clinical trial aims to evaluate the effect of a synbiotic containing Lactobacillus acidophilus and inulin on cognitive function in adults with obesity and mild cognitive impairment. Forty participants aged 30-40 years will be randomly assigned to two groups. Participants will receive either the synbiotic intervention or a control preparation, followed by crossover to the alternate intervention. Cognitive function will be evaluated using the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), and Memory Alteration Test (M@T). Fecal butyrate and Lactobacillus acidophilus, as well as serum inflammatory cytokines and BDNF, will also be assessed to explore potential mechanisms involving the gut-brain axis.

Source record: https://clinicaltrials.gov/study/NCT07810517

Facts

registry idNCT07810517
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionObesity (Disorder)
sponsorAnahuac University
sponsor classOTHER
enrollment40
start date2026-11-01
primary completion2027-02-02
completion2027-06-01
results postednot reported

Conditions

  • Obesity (Disorder)

Interventions

  • Synbiotic (Lactobacillus acidophilus LA-5 and Agave Inulin)

Countries

  • Mexico

Intervention types: DIETARY_SUPPLEMENT

Work with this record